![Cedric O'Gorman](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Cedric O'Gorman
Geen lopende functies
Profiel
Cedric O'Gorman formerly worked at Axsome Therapeutics, Inc., as Senior VP-Clinical Development & Medical Affairs, Intra-Cellular Therapies, Inc., as Vice President-Medical Affairs from 2014 to 2017, Relmada Therapeutics, Inc., as Chief Medical Officer from 2023 to 2024, and Alpha Cognition, Inc., as Chief Medical Officer from 2021 to 2023.
Dr. O'Gorman received his doctorate degree from National University of Ireland and Masters Business Admin degree in 2010 from The Leonard N Stern School of Business.
Eerdere bekende functies van Cedric O'Gorman
| Bedrijven | Functie | Einde |
|---|---|---|
| RELMADA THERAPEUTICS, INC. | Hoofd Techniek/Wetenschap/O&O | 03-01-2024 |
| ALPHA COGNITION INC. | Hoofd Techniek/Wetenschap/O&O | 06-01-2023 |
| AXSOME THERAPEUTICS, INC. | Hoofd Techniek/Wetenschap/O&O | 02-12-2021 |
| INTRA-CELLULAR THERAPIES, INC. | Hoofd Techniek/Wetenschap/O&O | 01-09-2017 |
Opleiding van Cedric O'Gorman
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
94
Eerstegraads connecties
6
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 6 |
|---|---|
Axsome Therapeutics, Inc.
 Axsome Therapeutics, Inc. BiotechnologyHealth Technology Develops and manufactures novel therapies for the management of central nervous system | Health Technology |
National University of Ireland
 National University of Ireland Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Intra-Cellular Therapies, Inc.
 Intra-Cellular Therapies, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that discovers, develops and commercializes small molecule drugs to treat neuropsychiatric and neurological disorders | Health Technology |
The Leonard N Stern School of Business
 The Leonard N Stern School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Relmada Therapeutics, Inc.
 Relmada Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops drug products for the treatment of depression and other central nervous system diseases | Health Technology |
Alpha Cognition, Inc.
 Alpha Cognition, Inc. Financial ConglomeratesFinance Develops pharmaceutical products for treating neurodegenerative diseases | Finance |
Kies MarketScreener 
